EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY-NC 4.0

Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of Current Evidence, Mechanisms, and Adverse Effects

Sam Woodowrth iD, Robert Hayden

Journal of Brown Hospital Medicine · 01.10.2026 · 5 (4)

DOI: 10.56305/001c.171893 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Brown Hospital Medicine, online erschienen am 01.10.2026. Verfasst von Sam Woodowrth und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Maine Medical Center. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 (SGLT2) inhibitors were initially developed as oral hypoglycemic agents for type 2 diabetes (T2D), but mounting evidence has solidified their role as practice-changing therapies for cardiovascular-kidney-metabolic (CKM) syndrome, which includes congestive heart failure (CHF) and chronic kidney disease (CKD). This review summarizes the pivotal randomized controlled trials evaluating SGLT2 inhibitors, highlighting their clinical efficacy, key mechanisms of action, and adverse effects. As indications continue to expand and more patients are prescribed SGLT2 inhibitors, hospitalists must have a thorough understanding of this important medication class.

Schlagwörter

Stichwörter der Autor:innen

SGLT2 inhibitorscardiovascular-kidney-metabolic syndromechronic kidney diseasecongestive heart failuretype 2 diabetes

Autor:innen und Institutionen

  • Department of Medicine Maine Medical Center.

ORCID-Profile: Sam Woodowrth

Zitieren

APA

Woodowrth, S., & Hayden, R. (2026). Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of Current Evidence, Mechanisms, and Adverse Effects. Journal of Brown Hospital Medicine, 5(4). https://doi.org/10.56305/001c.171893

Vancouver

Woodowrth S, Hayden R. Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of Current Evidence, Mechanisms, and Adverse Effects. Journal of Brown Hospital Medicine. 2026;5(4). doi:10.56305/001c.171893

BibTeX
@article{Woodowrth2026,
  author = {Woodowrth, Sam and Hayden, Robert},
  title = {Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of Current Evidence, Mechanisms, and Adverse Effects},
  journal = {Journal of Brown Hospital Medicine},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.56305/001c.171893}
}
Kostenlos starten →